u/One-Lengthiness-2175
Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M
ir.iovance.comH.C. Wainwright reiterated a Buy rating and $12.00 price target on Microbot Medical (NASDAQ:MBOT) following the company’s second-quarter performance.
reddit.comGUTS
Looking at the current situation I am going to build small position. The reverse split possibly August (1$/03/13/2026)
​
The news are strong.
​
What are your thoughts?
Any GREENS in your portfolio?
I have just CMPX up today.
Short borrow fees climbed to 35%
Looking good. The shorts are bleeding.
What are your plans for next week?
It's gona bee interesting week ahead. I will be watching closely any developments on the NASDAQ delisting filling and preopenig volumes, to decide my next steps. If any positive news comes out, there is possibility of short squeeze pump. There is over 10 million shares short with 2 days to cover. Possible +100 % price jump.
NASDAQ: Minimum Bid Price Noncompliant Company (NCM) 12/9/2025
​
There is a SAFX facing delisting on Monday. A reverse split is only possible with the written agreement of a 22% shareholder. The situation is a bit heated at the moment. There are also 10 million short shares with two days to cover. What will happen to the shorts if the company is delisted? I'm looking for serious scenarios.